Miami, FL Clinical Trials Report — April 2026

For Miami residents considering participation in clinical research, April 2026 presents a critical window to join studies before enrollment concludes. Across the city, 112 clinical trials are scheduled to close within the next 90 days. This urgency is particularly relevant for healthy volunteers, as 19 of these rapidly closing studies are still actively seeking participants without specific health conditions. Individuals interested in contributing to medical advancements should explore these options promptly.

Impending Deadlines for Research Participation

Patients managing certain health conditions also face impending deadlines to join research. Trials focused on various conditions, from metabolic disorders to neurological challenges, are among those with limited time remaining for enrollment. Conditions with trials closing soon include:

• Obesity (3 trials)
• Heart failure (3 trials)
• Primary lateral sclerosis (2 trials)
• Metastatic dedifferentiated liposarcoma (2 trials)
• Overweight (2 trials)
• Cancer (2 trials)
• Breast cancer (2 trials)
• Diabetic foot ulcer (DFU) (2 trials)
• Amyotrophic lateral sclerosis (2 trials)

In addition to these, 2 trials specifically seeking healthy volunteers are also nearing their enrollment deadlines, providing opportunities for those without specific health conditions to contribute to medical science before these studies conclude.

New Research Opportunities in Miami

This month, Miami saw the opening of 16 new clinical trials, a slight decrease from the 17 trials that launched in March 2026. Despite this small dip, the city continues to be a dynamic center for medical research, with a total of 1,305 clinical trials currently recruiting across 857 research facilities.

New trials this month are exploring a range of conditions, including abdominal pain, alopecia areata, asthma, autism, burning mouth syndrome, chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), early Alzheimer's disease, and emotional distress. Drug trials account for the majority of new studies, with 8 new drug trials, followed by 3 behavioral trials and 2 device trials. Notable sponsors initiating new research include Eli Lilly and Company and Florida International University, each sponsoring 2 new trials.

Spotlight on Key New Trials

April brings several high-profile new trials to Miami, including significant Phase 2 and Phase 3 studies from major sponsors. These trials offer participants the chance to engage with cutting-edge treatments and diagnostic approaches across a range of health challenges.

• Incyte Corporation is launching NCT07522073, "A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma." This important Phase 3 oncology trial seeks 588 participants to evaluate the efficacy and safety of a new combination therapy for metastatic pancreatic cancer.
• Nicklaus Children's Hospital f/k/a Miami Children's Hospital is sponsoring NCT07535294, "Assess Patient Readiness for Pelvic Ultrasound With the Use of Artificial Intelligence." This study, aiming for 520 participants, will assess bladder fullness using a handheld Point-of-Care Ultrasound (POCUS) with AI technology.
• Kinaset Therapeutics Inc. is initiating NCT07532265, "A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma." This dose-ranging study will evaluate a new treatment over a 12-week period in 512 participants with severe asthma not controlled by standard therapies.
• Praxis Precision Medicines is sponsoring NCT07505004, "Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures." This Phase 3, multicenter trial will evaluate the efficacy and safety of vormatrigine in 300 adult participants with focal seizures.
• Housey Healthcare ULC is leading NCT07546929, "HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes." This Phase 2 study, designed for 300 participants, aims to understand how HP-211 affects blood sugar levels in individuals with Type 2 Diabetes.
• AstraZeneca is sponsoring NCT07525375, "A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma." This Phase 2 study, involving 69 participants, will evaluate the effect of different doses of an inhaled treatment on lung function in children with asthma.

Miami's Research Powerhouses

Miami is home to several leading research institutions that consistently conduct a high volume of clinical trials. These facilities are key destinations for individuals seeking to participate in medical research:

• University of Miami (234 trials)
• University of Miami Miller School of Medicine-Sylvester Cancer Center (85 trials)
• Nicklaus Children's Hospital (59 trials)
• Miami Cancer Institute (52 trials)
• UM Sylvester Comprehensive Cancer Center at Kendall (35 trials)
• Research Site (30 trials)
• Sylvester Comprehensive Cancer Center (28 trials)
• University of Miami Miller School of Medicine (20 trials)
• University of Miami Hospital (17 trials)
• Miami Cancer Institute at Baptist Health, Inc. (15 trials)
• Bascom Palmer Eye Institute (15 trials)

The University of Miami system, including its Miller School of Medicine and Sylvester Cancer Centers, stands out as the most active research hub in the city. Nicklaus Children's Hospital offers specialized pediatric research, while the Miami Cancer Institute focuses on oncology advancements. Bascom Palmer Eye Institute is a notable center for ophthalmic studies.

Expanding Your Search: Nearby Options in Florida

While Miami offers a vast array of clinical trial opportunities, individuals may also find options in nearby communities within Florida. Cities with active trials include Tampa (10 trials), Jacksonville (7 trials), Orlando (6 trials), Gainesville (3 trials), Miami Lakes (3 trials), Sarasota (2 trials), Naples (2 trials), and Boca Raton (2 trials).

Who Can Participate?

Participation in clinical trials is open to a diverse range of individuals. Of the 16 new trials launched this month, 11 include older adults, ensuring that senior populations have ample opportunity to contribute to medical science. Additionally, 5 new trials are specifically designed for children. There is 1 new female-only trial and 1 new male-only trial. For individuals without a specific medical condition, 1 of the new trials launched this month is actively seeking healthy volunteers. Across Miami, a total of 122 clinical trials are currently recruiting healthy participants, providing numerous avenues for those interested in supporting medical research.

As we move further into spring, Miami's robust research community will continue to drive medical innovation, offering diverse opportunities for individuals to contribute to health advancements.